<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
APLS
Apellis
$
()


  • Apellis price target lowered by $4 at Wells Fargo, here's why

    9/24/2024 - 06:30am
  • Biotech Alert: Searches spiking for these stocks today

    9/23/2024 - 11:02am
  • Apellis price target lowered by $4 at Baird, here's why

    9/23/2024 - 06:53am
  • Apellis selloff brings 'very attractive entry point,' says Citi

    9/22/2024 - 11:06am
  • What You Missed On Wall Street On Friday

    9/20/2024 - 16:34pm
  • FedEx reports downbeat Q1, Nike vet returns as new CEO: Morning Buzz

    9/20/2024 - 12:04pm
  • Morning Movers: Apellis slips following negative CHMP opinion

    9/20/2024 - 08:52am
  • Apellis price target lowered by $3 at Mizuho, here's why

    9/20/2024 - 07:35am
  • Apellis reports CHMP confirmation of intravitreal pegcetacoplan negative opinion

    9/20/2024 - 05:37am
  • Apellis price target lowered by $7 at JPMorgan, here's why

    9/12/2024 - 20:20pm
  • Apellis price target lowered by $8 at JPMorgan, here's why

    8/13/2024 - 07:44am
  • Apellis price target raised by $3 at Wedbush, here's why

    8/9/2024 - 10:08am
  • Apellis price target raised by $10 at Baird, here's why

    8/9/2024 - 06:59am
  • Apellis price target raised by $8 at Goldman Sachs, here's why

    8/8/2024 - 18:25pm
  • Apellis, Sobi announces Phase 3 VALIANT study met primary endpoint

    8/8/2024 - 08:19am
dynamic_feed Breaking News